5 results match your criteria: "The 63600 hospital of PLA[Affiliation]"
Sci Rep
October 2024
The 63600 hospital of PLA, Dongfeng Chang District, Suzhou District, Jiuquan, 732750, China.
Melanoma Manag
June 2023
Department of Dermatology, Shaanxi Provincial People's Hospital, Xi'an 710068, China.
Aim: To identify distinct disulfidptosis-molecular subtypes and develop a novel prognostic signature.
Methods/materials: We integrated into this study multiple SKCM transcriptomic datasets from the Cancer Genome Atlas database and Gene Expression Omnibus dataset. The consensus clustering algorithm was applied to categorize SKCM patients into different DRG subtypes.
J Int Adv Otol
November 2023
Department of Neurology, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, China.
Background: We aimed to analyze the independent risk factors that affect the treatment outcomes of residual symptoms of cured benign paroxysmal positional vertigoand to construct a nomogram model.
Methods: A total of 186 benign paroxysmal positional vertigo patients who were treated in our hospital from June 2019 to August 2021 were selected. According to whether there were residual symptoms, they were divided into a group with residual symptoms (n=82) and a group without residual symptoms (n = 104).
Heliyon
May 2023
Department of Dermatology, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
Background: Anoikis, a form of apoptosis induced by cell detachment, plays a key role in cancer metastasis. However, the potential roles of anoikis-related genes (ARGs) in assessing the prognosis of skin cutaneous melanoma (SKCM) and the tumor microenvironment (TME) remain unclear.
Methods: The data from TCGA corresponding to transcriptomic expression patterns for patients with SKCM were downloaded and utilized to screen distinct molecular subtypes by a non-negative matrix factorization algorithm.
Front Genet
August 2021
Department of Oncology, Shaanxi Provincial People's Hospital, Xi'an, China.
Background: The existing studies indicate that RNA binding proteins (RBPs) are closely correlated with the genesis and development of cancers. However, the role of RBPs in cutaneous melanoma remains largely unknown. Therefore, the present study aims to establish a reliable prognostic signature based on RBPs to distinguish cutaneous melanoma patients with different prognoses and investigate the immune infiltration of patients.
View Article and Find Full Text PDF